Person:
DEMİRBÜKEN, İLKŞAN

Loading...
Profile Picture

Email Address

Birth Date

Research Projects

Organizational Units

Job Title

Last Name

DEMİRBÜKEN

First Name

İLKŞAN

Name

Search Results

Now showing 1 - 2 of 2
  • PublicationOpen Access
    A Better Way to Decrease Knee Swelling in Patients with Knee Osteoarthritis: A Single-Blind Randomised Controlled Trial
    (HINDAWI LTD, 2019-05-02) DEMİRBÜKEN, İLKŞAN; Sari, Zubeyir; Aydogdu, Onur; Demirbuken, Ilksan; Yurdalan, S. Ufuk; Polat, M. Gulden
    Objective. In this study, we compared the effects of intermittent pneumatic compression along with conventional treatment with cold-pack treatment along with conventional treatment on clinical outcomes in patients with knee osteoarthritis. Methods. Eighty-nine patients with knee osteoarthritis participated in this study. One group received ultrasound, transcutaneous electrical nerve stimulation, electrical stimulation, exercise, and cold packs. The second group received ultrasound, transcutaneous electrical nerve stimulation, electrical stimulation, exercise, and intermittent pneumatic compression. Range of motion, muscle strength, knee swelling, pain intensity, and functional status were measured at baseline and 4th week. Results. We found significant improvements in range of motion, muscle strength, pain intensity, and functional status after the treatment in both groups (p<0.05). When comparing the effects of these two treatment programs, it was observed that the intermittent pneumatic compression treatment group had a better outcome in terms of knee swelling (p=0.028). Conclusions. According to the results, we could report that intermittent pneumatic compression therapy in addition to conventional treatment has significant positive effects on clinical outcomes in patients with knee osteoarthritis. We could also report that intermittent pneumatic compression therapy along with conventional treatment is superior to cold-pack therapy along with conventional treatment in terms of knee swelling in patients with knee osteoarthritis. This trial is registered with NCT03806322.
  • PublicationOpen Access
    Does Kinesiophobia Effect One Day Physical Activity Behaviour and Functionality of Young People with Ankylosing Spondylitis?
    (MARMARA UNIV, INST HEALTH SCIENCES, 2020-03-31) DEMİRBÜKEN, İLKŞAN; Aydin, Gamze; Demirbuken, Ilksan; Mutlu, Ebru Kaya; Polat, Mine Gulden
    Objective: The aim of this study was to investigate the relationship between kinesiophobia, physical activity behaviour and functionality in patients with ankylosing spondylitis (AS). Methods: This study included 57 participants (mean age, 30.8 +/- 5.19 years) in 2 groups of AS and healthy controls. One day physical activity behaviour was evaluated with tri-axial accelerometer. Tri-axial accelerometer was recorded physical activity domains and intensities for 24 hours. Participants completed clinical questionnaires assessing pain, kinesophobia, disease activity, and functionality. Kinesiophobia and pain were quantified by the Tampa Scale for Kinesiophobia and Short-Form McGill Pain Questionnaire. Function and disease activity were rated by using the Bath Ankylosing Spondylitis Functional Index, and Bath Ankylosing Spondylitis Disease Activity Score. Results: There was no correlation between kinesiophobia and one day physical activity behaviour in AS patients group. There was a negative correlation between high physical activity level and disease activity(p<0.05, r:-.519) and there was a negative correlation between high and moderate physical activity levels, and functionality (p <0.05, r:-.555 r-395, respectively). Conclusion: According to the results of this study showed that; there was a relationship between disease activity, functionality, and one day physical activity behaviour. On the other hand, there was not any relation between pain intensity, kinesophobia and data obtained from accelerometer. Further studies with larger sample size and longer time periods should be carried out to reveal physical activity behaviours and its related factors in AS patients who will survive with this disease for years.